Compared with the triple negative breast cancer patients, patients with the HER2 overexpression subtype were more likely to have positive NSLNs, whereas the patients with the luminal A and luminal B subtypes did not significantly differ in NSLN metastasis. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.